GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Know Labs Inc (AMEX:KNW) » Definitions » ROCE %
中文

Know Labs (Know Labs) ROCE %

: -554.85% (As of Dec. 2023)
View and export this data going back to 2006. Start your Free Trial

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Know Labs's annualized ROCE % for the quarter that ended in Dec. 2023 was -554.85%.


Know Labs ROCE % Historical Data

The historical data trend for Know Labs's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Know Labs Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -11,232.26 -204.00 -217.63

Know Labs Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -169.21 -367.64 -628.78 -575.20 -554.85

Know Labs ROCE % Calculation

Know Labs's annualized ROCE % for the fiscal year that ended in Sep. 2023 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Sep. 2023 )  (A: Sep. 2022 )(A: Sep. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Sep. 2023 )  (A: Sep. 2022 )(A: Sep. 2023 )
=-14.9/( ( (13.758 - 3.809) + (8.266 - 4.522) )/ 2 )
=-14.9/( (9.949+3.744)/ 2 )
=-14.9/6.8465
=-217.63 %

Know Labs's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2023 )  (Q: Sep. 2023 )(Q: Dec. 2023 )
=-13.788/( ( (8.266 - 4.522) + (5.013 - 3.787) )/ 2 )
=-13.788/( ( 3.744 + 1.226 )/ 2 )
=-13.788/2.485
=-554.85 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Know Labs  (AMEX:KNW) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Know Labs ROCE % Related Terms

Thank you for viewing the detailed overview of Know Labs's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Know Labs (Know Labs) Business Description

Traded in Other Exchanges
N/A
Address
500 Union Street, Suite 810, Seattle, WA, USA, 98101
Know Labs Inc is a medical diagnostic. The company is focused on the development, marketing, and sales of proprietary technologies that are capable of uniquely identifying or authenticating almost any substance or material using electromagnetic energy to record, detect, and identify the signature of the substance or material known as Bio-RFID and ChromaID technologies. It is developing a wearable device that will measure blood glucose without fingersticks or microneedles.
Executives
Todd Baszucki 10 percent owner 519 LOMA ALTA ROAD, CARMEL CA 93923
Jessica English officer: Chief Marketing Officer 34 GRANADA DRIVE, CORTE MADERA CA 94925
Leonardo Mouta Trautwein officer: Chief Marketing Officer PO BOX 2021, PARK CITY UT 84060
Takesako Ichiro John Paul director 500 UNION STREET, SUITE 420, SEATTLE WA 98101
Peter J Conley officer: Chief Financial Officer 3658 PRICE HILLS DRIVE, SAINT GEORGE UT 84790
Steven T Kent officer: Chief Product Officer 185 CHANNEL ST, APT 545, SAN FRANCISCO CA 94158
William Arthur Owens director C/O CENTURYLINK, INC., 100 CENTURYLINK DRIVE, MONROE LA 71203
Ronald P Erickson director, officer: Chairman 9437 NE CORAL COURT, BAINBRIDGE ISLAND WA 98110
Jon Pepper director 500 UNION STREET, SUITE 810, SEATTLE WA 98101
Phillip Bosua director, 10 percent owner, officer: CEO and President 500 UNION STREET, SUITE 810, SEATTLE WA 98101
Jeff T Wilson officer: CFO
Jeffrey Richard Kruse other: Pres. of TransTech Systems Inc 12142 NE SKY LANE, SUITE 130, AURORA OR 97002
Todd Martin Sames officer: V.P. of Business Development 500 UNION STREET, SUITE 420, SEATTLE WA 98101
Richard Mander officer: VP Product Mgmnt & Technology 500 UNION STREET, STE 406, SEATTLE WA 98101
Bonderson Paul R Jr director

Know Labs (Know Labs) Headlines

From GuruFocus

Know Labs, Inc. to Present at the LD 500 Virtual Conference

By ACCESSWIRE ACCESSWIRE 08-25-2020